dumping syndrome glp-1 After Bariatric Surgery: Advanced Nutritional Perspectives and Integrated Pharmacological Management Dumping Syndrome Gastric Bypass

Currently, there is no approved treatment for NAFLD and NASH

Purpose of Review Hypertension is the leading modifiable risk factor for cardiovascular disease

as the science nerd that I am

From study baseline to the end of follow-up, GLP-1RAs treatment resulted in statistically significant decreases in weight (MD=-2.32 kg, 95% CI: -4.21 to -0.43) and BMI (MD=-0.82 kg/m2, 95% CI: -1.47 to -0.17)

GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure

The long-term business implications could be massive